Stonepine Capital Management, LLC - Q2 2014 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q2 2014
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CTI Biopharmap Corp.24Q1 202314.8%
APOLLO ENDOSURGERY INC23Q1 202315.6%
XOMA CORP20Q3 20235.7%
Cumberland Pharmaceuticals, Inc.19Q4 20207.0%
Amarin Corp PLC - SPONS ADR14Q3 202223.2%
VANDA PHARMACEUTICALS INC14Q3 202320.9%
BIODELIVERY SCIENCES INTL14Q1 202012.9%
AFFIMED NV13Q3 20227.7%
ALIMERA SCIENCES INC13Q3 20194.2%
VIVEVE MEDICAL INC12Q2 201915.3%

View Stonepine Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Stonepine Capital Management, LLC Q2 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CTI BIOPHARMA CORPApril 13, 20237,018,0465.3%
ADMA BIOLOGICS, INC.February 13, 20236,940,0003.1%
Amryt Pharma plcFebruary 13, 202331,666,1959.9%
Apollo Endosurgery, Inc.February 13, 20234,351,0889.0%
Conformis IncFebruary 13, 2023748,1949.9%
Ovid Therapeutics Inc.Sold outFebruary 13, 202300.0%
Adamas Pharmaceuticals IncSold outFebruary 14, 202200.0%
CATALYST BIOSCIENCES, INC.Sold outFebruary 14, 202200.0%
Conformis IncFebruary 14, 202214,768,8237.9%
YUMANITY THERAPEUTICS, INC.Sold outFebruary 14, 202200.0%

View Stonepine Capital Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-04-19
13F-HR2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13

View Stonepine Capital Management, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Stonepine Capital Management, LLC's holdings

CSVXLS